Answers are grounded in this paper and cite their sources.
The highly enantioselective hydrogenation of ethyl 5,5‐dimethoxy‐3‐oxopentanoate (3) to ethyl 3‐hydroxy‐5,5‐dimethoxypentanoate (4) – a key intermediate in the synthesis of pharmacologically important statin drugs – has been investigated. The stereochemistry of the catalytic hydrogenation of the β‐keto ester in the presence of a number of homogeneous chiral RhI and RuII complexes with phosphane ligands has been studied. The highest enantioselectivity for the homogeneous hydrogenation of 3 (up to 98.7 % ee) was achieved through an optimized version of Genêt's procedure with a Ru[(R)‐BINAP]Cl2 pre‐catalyst (substrate/catalyst ratio up to 20 000:1, 50 bar H2, 50 °C, in MeOH). The transformation of alcohol R‐(4) into ylide R‐(6) as an important precursor of the chiral side chain of rosuvastatin is also illustrated. (© Wiley‐VCH Verlag GmbH & Co. KGaA, 69451 Weinheim, Germany, 2008)
No takes yet. Share an insight, caveat, or question.
Korostylev et al. (2008) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: